Cancer drugs approved based on biomarkers and not tumor type - FDA approval of pembrolizumab for mismatch repair-deficient solid cancers

Vinay Prasad, Victoria Kaestner, Sham Mailankody

Research output: Contribution to journalShort surveypeer-review

92 Scopus citations
Original languageEnglish (US)
Pages (from-to)157-158
Number of pages2
JournalJAMA Oncology
Issue number2
StatePublished - Feb 2018

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this